Jpmorgan Chase & CO Opiant Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$10.12 - $23.32 $75,555 - $174,107	-7,466 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$19.54 - $33.59 $14,127 - $24,285	723 Added 10.72%	7,466 $160,000
Q4 2021 Feb 10, 2022	BUY	$22.51 - $36.79 $125,695 - $205,435	5,584 Added 481.79%	6,743 $227,000
Q3 2021 Nov 12, 2021	BUY	$13.28 - $25.79 $15,391 - $29,890	1,159 New	1,159 $30,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.